Burn wounds infected with Pseudomonas aeruginosa triggers weight loss in rats

BMC Surgery

Volumn 5, Issue , 2005, Pages

  Steinstraesser, Lars ^a,b   Burkhard, Olaf ^a,c   Fan, Ming H ^a   Jacobsen, Frank ^c   Lehnhardt, Marcus ^c   Su, Grace ^b   Daigler, Adrien ^c   Steinau, Hans U ^c   Remick, Daniel ^b   Wang, Stewart C ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ENDOTOXIN; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD ANALYSIS; BURN INFECTION; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOTOXEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; MONITORING; NONHUMAN; PSEUDOMONAS AERUGINOSA; QUANTITATIVE ANALYSIS; RAT; UPREGULATION; WEIGHT REDUCTION; ANIMAL; BLOOD; BURN; DISEASE MODEL; LYMPHOCYTE; MALE; METABOLISM; PATHOPHYSIOLOGY; PSEUDOMONAS INFECTION; SPRAGUE DAWLEY RAT; WOUND INFECTION;

ANIMALS; BURNS; CYTOKINES; DISEASE MODELS, ANIMAL; ENDOTOXINS; LYMPHOCYTES; MALE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA; WEIGHT LOSS; WOUND INFECTION;

EID: 26444548007     PISSN: 14712482     EISSN: 14712482     Source Type: Journal    
DOI: 10.1186/1471-2482-5-19     Document Type: Article

References (36)

1. Baue AE, Durham R, Faist E: Systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), multiple organ failure (MOF): are we winning the battle? Shock 1998, 10(2):79-89.
2. Harris BH, Gelfand JA: The immune response to trauma. Semin Pediatr Surg 1995, 4(2):77-82.
3. Nguyen TT, Gilpin DA, Meyer NA, Herndon DN: Current treatment of severely burned patients. Ann Surg 1996, 223(1):14-25.
4. Saffle JR, Sullivan JJ, Tuohig GM, Larson CM: Multiple organ failure in patients with thermal injury. Crit Care Med 1993, 21(11):1673-1683.
5. Still JMJ, Belcher K, Law EJ: Experience with polymicrobial sepsis in a regional burn unit. Burns 1993, 19(5):434-436.
6. Teodorczyk-Injeyan JA, Sparkes BG, Mills GB, Peters WJ, Falk RE: Impairment of T cell activation in burn patients: a possible mechanism of thermal injury-induced immunosuppression. Clin Exp Immunol 1986, 65(3):570-581.
7. Steinstraesser L, Oezdogan Y, Wang SC, Steinau HU: Host defense peptides in burns. Burns 2004, 30(7):619-627.
8. Nizet V, Ohtake T, Lauth X, Trowbridge J, Rudisill J, Dorschner RA, Pestonjamasp V, Piraino J, Huttner K, Gallo RL: Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 2001, 414(6862):454-457.
9. Meakins JL: Etiology of multiple organ failure. J Trauma 1990, 30(12 Suppl):S165-8.
10. Hengge UR, Benninghoff B, Ruzicka T, Goos M: Topical immunomodulators - progress towards treating inflammation, infection, and cancer. Lancet Infect Dis 2001, 1(3):189-198.
11. Kawakami M, Terai C, Okada Y: Changes of the interleukin-6 levels in skin at different sites after thermal injury. J Trauma 1998, 44(6):1056-1063.
12. Reddy RC, Chen GH, Tekchandani PK, Standiford TJ: Sepsis-induced immunosuppression: from bad to worse. Immunol Res 2001, 24(3):273-287.
13. Steinstraesser L, Fohn M, Klein RD, Aminlari A, Remick DG, Su GL, Wang SC: Feasibility of biolistic gene therapy in burns. Shock 2001, 15(4):272-277.
14. Jacobsen F, Baraniskin A, Mertens J, Mittler D, Mohammadi-Tabrisi A, Schubert S, Soltau M, Lehnhardt M, Behnke B, Gatermann S, Steinau HU, Steinstraesser L: Activity of histone H1.2 in infected burn wounds. J Antimicrob Chemother 2005, 55(5):735-741.
15. Jacobsen F, Mittler D, Hirsch T, Gerhards A, Lehnhardt M, Voss B, Steinau HU, Steinstraesser L: Transient cutaneous adenoviral gene therapy with human host defense peptide hCAP-18/LL-37 is effective for the treatment of burn wound infections. Gene Ther 2005.
16. Steinstraesser L, Klein RD, Aminlari A, Fan MH, Khilanani V, Remick DG, Su GL, Wang SC: Protegrin-1 enhances bacterial killing in thermally injured skin. Crit Care Med 2001, 29(7):1431-1437.
17. Steinstraesser L, Tack BF, Waring AJ, Hong T, Boo LM, Fan MH, Remick DI, Su GL, Lehrer RI, Wang SC: Activity of novispirin G10 against Pseudomonas aeruginosa in vitro and in infected burns. Antimicrob Agents Chemother 2002, 46(6):1837-1844.
18. Dehne MG, Sablotzki A, Hoffmann A, Muhling J, Dietrich FE, Hempelmann G: Alterations of acute phase reaction and cytokine production in patients following severe burn injury. Burns 2002, 28(6):535-542.
19. Cohen J: The immunopathogenesis of sepsis. Nature 2002, 420(6917):885-891.
20. Brun-Buisson C: The epidemiology of the systemic inflammatory response. Intensive Care Med 2000, 26 Suppl 1:S64-74.
21. Angus DC, Wax RS: Epidemiology of sepsis: an update. Crit Care Med 2001, 29(7 Suppl):S109-16.
22. Long CL: Energy balance and carbohydrate metabolism in infection and sepsis. Am J Clin Nutr 1977, 30(8):1301-1310.
23. Klein RD, Su GL, Aminlari A, Zhang H, Steinstraesser L, Alarcon WH, Wang SC: Skin lipopolysaccharide-binding protein and IL-1beta production after thermal injury. J Burn Care Rehabil 2000, 21(4):345-352.
24. Steinstraesser L, Burghard O, Nemzek J, Fan MH, Merry A, Remick DI, Su GL, Steinau HU, Wang SC: Protegrin-1 increases bacterial clearance in sepsis but decreases survival. Crit Care Med 2003, 31(1):221-226.
25. Marano MA, Moldawer LL, Fong Y, Wei H, Minei J, Yurt R, Cerami A, Lowry SF: Cachectin/TNF production in experimental burns and Pseudomonas infection. Arch Surg 1988, 123(11):1383-1388.
26. Fathalla B, Hamada K, Vannier E, Smith D, Edwards C, Roubenoff R: Effects of aging and cytokine blockade on inflammatory cachexia. Clin Exp Rheumatol 2004, 22(1):85-90.
27. Drost AC, Burleson DG, Cioffi WGJ, Mason ADJ, Pruitt BAJ: Plasma cytokines after thermal injury and their relationship to infection. Ann Surg 1993, 218(1):74-78.
28. Biffl WL, Moore EE, Moore FA, Peterson VM: Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation? Ann Surg 1996, 224(5):647-664.
29. Kowal-Vern A, Walenga JM, Hoppensteadt D, Sharp-Pucci M, Gamelli RL: Interleukin-2 and interleukin-6 in relation to burn wound size in the acute phase of thermal injury. J Am Coll Surg 1994, 178(4):357-362.
30. Dinarello CA, Cannon JG, Wolff SM, Bernheim HA, Beutler B, Cerami A, Figari IS, Palladino MAJ, O'Connor JV: Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med 1986, 163(6):1433-1450.
31. Friedman G, Jankowski S, Marchant A, Goldman M, Kahn RJ, Vincent JL: Blood interleukin 10 levels parallel the severity of septic shock. J Crit Care 1997, 12(4):183-187.
32. van der Poll T, Speelman P, van Deventer SJ: [Immunology in clinical practice. VIII. Role of cytokines in the pathogenesis of bacterial infections]. Ned Tijdschr Geneeskd 1998, 142(1):14-17.
33. Van der Poll T, Lowry SF: Epinephrine inhibits endotoxin-induced IL-1 beta production: roles of tumor necrosis factor-alpha and IL-10. Am J Physiol 1997, 273(6 Pt 2):R1885-90.
34. Schwacha MG, Ayala A, Chaudry IH: Insights into the role of gammadelta T lymphocytes in the immunopathogenic response to thermal injury. J Leukoc Biol 2000, 67(5):644-650.
35. Schwacha MG, Somers SD: Thermal injury induces macrophage hyperactivity through pertussis toxin-sensitive and -insensitive pathways. Shock 1998, 9(4):249-255.
36. Seitz M, Loetscher P, Dewald B, Towbin H, Gallati H, Baggiolini M: Interleukin-10 differentially regulates cytokine inhibitor and chemokine release from blood mononuclear cells and fibroblasts. Eur J Immunol 1995, 25(4):1129-1132.